SCHEMBL1094428

SCHEMBL1094428

C(=NOCCN1CCCCC1)c1cncnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
KDR P35968 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
LTA4H P09960 4/20 0.36
HRH3 Q9Y5N1 5/20 0.36
KCNH2 Q12809 1/20 0.36
PSMB1 P20618 1/20 0.36
PSMB5 P28074 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1096014 0.85 HDAC3 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30420765 0.77 TAAR1 (0.54) CHRNB2CHRNA4TAAR1LTA4HHRH3
SCHEMBL2324632 0.77 TAAR1 (0.54) CHRNB2CHRNA4TAAR1LTA4HHRH3
SCHEMBL7097968 0.70 CHRNB2 (0.66) CHRNB2CHRNA4LTA4HHRH3PSMB1
SCHEMBL1095002 0.70 SMN1; SMN2 (0.38) KDRTAAR1
SCHEMBL15865996 0.70 HRH3 (0.38) HRH3PSMB1PSMB5PSMB2
SCHEMBL9944259 0.69 PSMB1 (0.44) HRH3KCNH2PSMB1PSMB5PSMB2
SCHEMBL27995047 0.68 HRH3 (0.60) CHRNB2CHRNA4HRH3KCNH2
SCHEMBL29094266 0.68 TAAR1 (0.74) TAAR1LTA4H
SCHEMBL6979241 0.68 TDP1 (0.36) LTA4HHRH3PSMB1PSMB5PSMB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153791-B2 substituted pyrimidine compoundssuch as 4-amino-6-(3-chloro-4-fluoro-phenylamino)-pyrimidine-5-carbaldehyde O-methyl oxime, used for treating, preventing or ameliorating a chronic or acute protein kinase mediated diseasea, disorders or conditions JANSSEN PHARMACEUTICA N.V. (BE) 2012-04-10 US claimed
US-8153791-B2 substituted pyrimidine compoundssuch as 4-amino-6-(3-chloro-4-fluoro-phenylamino)-pyrimidine-5-carbaldehyde O-methyl oxime, used for treating, preventing or ameliorating a chronic or acute protein kinase mediated diseasea, disorders or conditions JANSSEN PHARMACEUTICA N.V. (BE) 2012-04-10 US disclosed